A scoping review of interventions in childhood tuberculosis prevention and treatment

Read full text Summarise with VIRAT
Authors: Md Zamiur Rahaman, Tahmina Alam, Syeda Shamsun Nahar, Ridwana Nahrin, Israt Jahan Bushra, Shahriar Ahmed, Sayera Banu, Lubaba Shahrin
Cited by: 0
References: 76

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective: This scoping review aims to identify and map the available evidence on interventions for the prevention and treatment of childhood TB, confirm current practice, explore variation, and identify emerging approaches. Study design: Scoping review. Method: This scoping review was conducted using established methods and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist. The protocol was registered with the Open Science Framework. Selection criteria were defined using the PCC framework, including population (children aged 0-18 years), concept (prevention and treatment of tuberculosis), and context (global settings). Studies with control groups were included, such as randomised controlled trials (RCTs), quasi-experimental studies, cohort studies, case-control studies, and cross-sectional studies. Electronic databases (PubMed, Web of Science, Scopus, Cochrane Library, and EMBASE) and websites of global health agencies (e.g., USAID, UNICEF, WHO, and CDC) were searched. Results: Following a comprehensive search and screening process, 41 studies were included. Of these, 15 were conducted in the African region (with South Africa contributing the most, n = 7), followed by Southeast Asia (n = 12), Europe (n = 6), the Western Pacific (n = 4), the Eastern Mediterranean (Pakistan, n = 2), the Americas (USA, n = 1), and one multi-country study. Eighteen studies focused on TB prevention, 22 on treatment, and one on both. The review found that combining pharmaceutical and non-pharmaceutical interventions improved prevention outcomes, with treatment completion rates reaching up to 99% and reductions in mortality. The BCG vaccine showed variable efficacy (22-92%), with over 70% protection against TB meningitis reported in several regions. Treatment success rates for drug-sensitive TB reached up to 97%. New regimens incorporating bedaquiline and delamanid for multidrug-resistant (MDR-TB) and extensively drug-resistant TB (XDR-TB) showed cure rates as high as 94.6%. Conclusion: Overall, shorter treatment regimens were associated with higher completion rates, although evidence on long-term cure remains limited.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Diagnosis and treatment of tuberculosis

Publication details

Journal / source
Public Health in Practice
Volume
11
Pages
100775–100775
Publication date
20 March 2026
Language
EN